Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | |||
group_5_presentation_2_-_biological_weapons [2019/03/09 17:25] garciav [Class B- Food Safety Threats: Salmonella] |
group_5_presentation_2_-_biological_weapons [2019/03/09 17:26] (current) garciav [References] |
||
---|---|---|---|
Line 127: | Line 127: | ||
Henderson, D. A., Inglesby, T. V., Bartlett, J. G., Ascher, M. S., Eitzen, E., Jahrling, P. B., ... & O'toole, T. (1999). Smallpox as a biological weapon: medical and public health management. Jama, 281(22), 2127-2137. | Henderson, D. A., Inglesby, T. V., Bartlett, J. G., Ascher, M. S., Eitzen, E., Jahrling, P. B., ... & O'toole, T. (1999). Smallpox as a biological weapon: medical and public health management. Jama, 281(22), 2127-2137. | ||
+ | |||
+ | Hodivala-Dilke, K. (2008). αvβ3 integrin and angiogenesis: a moody integrin in a changing environment. Current opinion in cell biology, 20(5), 514-519. | ||
Holter, H. (1959). Pinocytosis. In International review of cytology (Vol. 8, pp. 481-504). Academic Press. | Holter, H. (1959). Pinocytosis. In International review of cytology (Vol. 8, pp. 481-504). Academic Press. | ||
Line 137: | Line 139: | ||
Kadlec, R. P., Zelicoff, A. P., & Vrtis, A. M. (1997). Biological weapons control: prospects and implications for the future. Jama, 278(5), 351-356. | Kadlec, R. P., Zelicoff, A. P., & Vrtis, A. M. (1997). Biological weapons control: prospects and implications for the future. Jama, 278(5), 351-356. | ||
+ | |||
+ | Mackow, E. R., & Gavrilovskaya, I. N. (2001). Cellular receptors and hantavirus pathogenesis. In Hantaviruses (pp. 91-115). Springer, Berlin, Heidelberg. | ||
+ | |||
+ | Markotic, A., Gagro, A., Dasic, G., Kuzman, I., Lukas, D., Nichol, S., ... & Dekaris, D. (2002). Immune parameters in hemorrhagic fever with renal syndrome during the incubation and acute disease: case report. Croatian medical journal, 43(5), 587-590. | ||
Newman, T. (2018, February 28). Biological weapons and bioterrorism: Past, present, and future. Retrieved from https://www.medicalnewstoday.com/articles/321030.php | Newman, T. (2018, February 28). Biological weapons and bioterrorism: Past, present, and future. Retrieved from https://www.medicalnewstoday.com/articles/321030.php | ||
Line 147: | Line 153: | ||
Robertson, A. G., & Robertson, L. J. (1995). From asps to allegations: biological warfare in history. Military medicine, 160(8), 369-373. | Robertson, A. G., & Robertson, L. J. (1995). From asps to allegations: biological warfare in history. Military medicine, 160(8), 369-373. | ||
+ | |||
+ | Safronetz, D., Prescott, J., Feldmann, F., Haddock, E., Rosenke, R., Okumura, A., ... & Scott, D. P. (2014). Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques. Proceedings of the National Academy of Sciences, 111(19), 7114-7119. | ||
+ | |||
+ | Schmaljohn, C. S., Hasty, S. E., Dalrymple, J. M., LeDuc, J. W., Lee, H. W., Von Bonsdorff, C. H., ... & Regnery, H. L. (1985). Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science, 227(4690), 1041-1044. | ||
Tasota, F. J., Henker, R. A., & Hoffman, L. A. (2002). Anthrax as a biological weapon: an old disease that poses a new threat. Critical care nurse, 22(5), 21-34. | Tasota, F. J., Henker, R. A., & Hoffman, L. A. (2002). Anthrax as a biological weapon: an old disease that poses a new threat. Critical care nurse, 22(5), 21-34. | ||
Line 155: | Line 165: | ||
WHO. (2019). Frequently asked questions regarding the deliberate use of biological agents and chemicals as weapons. Retrieved from https://www.who.int/csr/delibepidemics/faqbioagents/en/ | WHO. (2019). Frequently asked questions regarding the deliberate use of biological agents and chemicals as weapons. Retrieved from https://www.who.int/csr/delibepidemics/faqbioagents/en/ | ||
+ | |||
+ | Yi J, Xu Z, Zhuang R, Wang J, Zhang Y, Ma Y, Liu B, Zhang Y, Zhang C, Yan G, Zhang F, Xu Z, Yang A, Jin B (2013). "Hantaan virus RNA load in patients having hemorrhagic fever with renal syndrome: correlation with disease severity". J. Infect. Dis. 207(9): 1457–61. doi:10.1093/infdis/jis475. PMID 22869912. | ||